Monocarboxylate transport modulators and uses thereof
AssigneeNirogyone Therapeutics, Inc.
InventorsVincent Sandanayaka, Qiong Wu
Life of this patent
Estimating the term…
Loading patent…
AssigneeNirogyone Therapeutics, Inc.
InventorsVincent Sandanayaka, Qiong Wu
Estimating the term…
The invention generally relates to the field of monocarboxylate transport modulators, e.g., monocarboxylate transport inhibitors, and more particularly to new substituted-quinolone compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in treating, modulating, forestalling and/or reducing physiological conditions associated with monocarboxylate transport activity such as in treating cancer and other neoplastic disorders, inflammatory diseases, disorders of abnormal tissue growth and fibrosis including cardiomyopathy, obesity, diabetes, cardiovascular diseases, tissue and organ transplant rejection, and malaria.
A compound having the formula:
Dependencies are inferred from the claim text.